MYPN: A Potential Drug Target for MS (G84665)

Target Name: MYPN

NCBI ID: G84665

MYPN

MYPN: A Potential Drug Target for MS

Myopalladin (MYPN) is a protein that is expressed in the myelin sheath of the nervous system. It is a key component of the myelin sheath and helps to maintain the structural integrity of the nervous system.MYPN has been identified as a potential drug target (or biomarker) due to its unique structure and its involvement in the development and progression of multiple sclerosis (MS).

Structure and Function

MYPN is a transmembrane protein that is composed of 116 amino acid residues. It has a molecular weight of 17.1 kDa and a calculated pI of 4.9.MYPN is expressed in the myelin sheath of the nervous system and is involved in the production and maintenance of the myelin sheath. It is a critical protein for the structural integrity of the nervous system and plays a key role in the development and progression of MS.

MYPN is involved in the production and maintenance of the myelin sheath

The myelin sheath is a protective covering that surrounds the nervous system and helps to insulate it. The myelin sheath is produced by the myelinoid cells, which are a type of glial cell that are responsible for producing the myelin sheath.MYPN is one of the key proteins that is produced by these cells and helps to maintain the structural integrity of the myelin sheath.

MYPN is involved in the regulation of myelin basic protein (MBP)

MBP is a key component of the myelin sheath and is responsible for maintaining the structural integrity of the myelin sheath.MYPN is involved in the regulation of MBP levels in the myelinoid cells. It does this by interacting with the cytoplasmic region of MBP and by helping to ensure that MBP is properly targeted to the myelinoid cell.

MYPN is involved in the regulation of myelin phosphorylase (MP)

MP is a enzyme that is involved in the breakdown of myelin phosphate, which is an important component of the myelin sheath.MYPN is involved in the regulation of MP activity in the myelinoid cells. It does this by interacting with the active site of MP and by helping to ensure that MP is properly regulated.

MYPN is involved in the regulation of myelin protein zero (MPZ)

MPZ is a protein that is involved in the regulation of many cellular processes in the nervous system. It is produced by the myelinoid cells and is involved in the production and maintenance of the myelin sheath.MYPN is involved in the regulation of MPZ activity in the myelinoid cells. It does this by interacting with the cytoplasmic region of MPZ and by helping to ensure that MPZ is properly targeted to the myelinoid cell.

MYPN is involved in the regulation of myelin associated protein (MAP)

MAP is a protein that is involved in the regulation of many cellular processes in the nervous system. It is produced by the myelinoid cells and is involved in the production and maintenance of the myelin sheath.MYPN is involved in the regulation of MAP activity in the myelinoid cells. It does this by interacting with the cytoplasmic region of MAP and by helping to ensure that MAP is properly targeted to the myelinoid cell.

MYPN is involved in the regulation of myelin associated protein (MAP)

MAP is a protein that is involved in the regulation of many cellular processes in the nervous system. It is produced by the myelinoid cells and is involved in the production and maintenance of the myelin sheath.MYPN is involved in the regulation of MAP activity in the myelinoid cells. It does this by interacting with the cytoplasmic region of MAP and by helping to ensure that MAP is properly targeted to the myelinoid cell.

MYPN is involved in the regulation of myelin associated protein (MAP)

MAP is a protein that is involved in the regulation of many cellular

Protein Name: Myopalladin

Functions: Component of the sarcomere that tethers together nebulin (skeletal muscle) and nebulette (cardiac muscle) to alpha-actinin, at the Z lines

The "MYPN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYPN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets